Ad
NVO Short Information Novo Nordisk A/S
Short Information | Novo Nordisk A/S (NYSE:NVO)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 532,116 |
| Total Actual Volume | 108,723,341 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 26,606 |
| Average Short Percentage | 0.52% |
Is there a NVO Short Squeeze or Breakout about to happen?
See the NVO Short Analysis for free Sign up or Login
Powered by Squeeze Report
NVO Twenty Trading Day's Volume to Short Volume Chart
NVO Twenty Trading Day Price Chart
NVO Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 12-12-2024 | $110.88 | $108.61 | $111.1691 | $108.41 | 3,641,017 | 9,587 | 0.26% |
| 12-11-2024 | $110.45 | $111.69 | $112.52 | $110.02 | 6,545,662 | 19,518 | 0.3% |
| 12-10-2024 | $111.55 | $109.19 | $111.55 | $108.7 | 4,621,729 | 16,301 | 0.35% |
| 12-09-2024 | $111.72 | $111.08 | $111.99 | $110.3 | 4,908,910 | 16,389 | 0.33% |
| 12-06-2024 | $109.93 | $110.77 | $111.3061 | $109.75 | 6,045,653 | 6,292 | 0.1% |
| 12-05-2024 | $108.62 | $108.82 | $109.3243 | $108.23 | 3,914,363 | 3,369 | 0.09% |
| 12-04-2024 | $110.22 | $108.97 | $110.52 | $108.96 | 4,485,590 | 6,457 | 0.14% |
| 12-03-2024 | $110.78 | $109.2 | $110.88 | $109.05 | 4,828,723 | 12,651 | 0.26% |
| 12-02-2024 | $108.93 | $108.67 | $109.14 | $108.15 | 4,948,303 | 10,567 | 0.21% |
| 11-29-2024 | $105.43 | $106.8 | $107.4 | $105.3485 | 2,775,149 | 6,780 | 0.24% |
| 11-27-2024 | $105.79 | $106.13 | $106.13 | $104.961 | 3,990,584 | 24,600 | 0.62% |
| 11-26-2024 | $106.67 | $106.13 | $107.7 | $105.63 | 6,761,371 | 22,337 | 0.33% |
| 11-25-2024 | $105.31 | $104.56 | $105.92 | $104.0001 | 4,294,622 | 16,859 | 0.39% |
| 11-22-2024 | $103.91 | $105.06 | $106.24 | $103.86 | 6,143,345 | 117,375 | 1.91% |
| 11-21-2024 | $103.18 | $102.63 | $103.22 | $101.5113 | 6,185,447 | 12,844 | 0.21% |
| 11-20-2024 | $103.43 | $105.27 | $105.74 | $103 | 7,520,708 | 11,087 | 0.15% |
| 11-19-2024 | $101.18 | $102.63 | $103.12 | $101.14 | 5,778,724 | 8,549 | 0.15% |
| 11-18-2024 | $100.32 | $99.81 | $101 | $99.42 | 8,790,052 | 16,955 | 0.19% |
| 11-15-2024 | $101.67 | $101.74 | $102.34 | $100.32 | 8,076,248 | 17,439 | 0.22% |
| 11-14-2024 | $106.83 | $105.32 | $107 | $105 | 4,467,141 | 176,160 | 3.94% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-12-13 05:03:00 ET Finding a good growth stock to buy these days isn't easy. Many that have been doing well are at sky-high valuations. Investing in a stock at a steep premium can limit the return you can earn from it, or worse, result in a significant loss in the event of slowing marke...
-
2024-12-10 04:10:00 ET One particular healthcare stock has shown its ability to soar on good news -- and it's had plenty of it. This year the company reported solid results from trials of a candidate meant to address one of today's hottest growth areas: weight loss. The weight loss drug mar...
-
2024-12-09 04:59:00 ET According to a sneak peek of the data from one of Eli Lilly 's (NYSE: LLY) late-stage clinical trials, the cardiometabolic medicine juggernaut now looks even stronger in comparison to its similarly powerful arch-rival, Novo Nordisk , (NYSE: NVO) and it...